ASP.TO

Acerus Pharmaceuticals Corporation [ASP.TO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ASP.TO Stock Summary

In the News

ASP.TO Financial details

Company Rating
Neutral
Market Cap
2.77M
Income
-32.27M
Revenue
3.04M
Book val./share
-1.8
Cash/share
0.39
Dividend
-
Dividend %
-
Employees
14
Optionable
No
Shortable
Yes
Earnings
08 May 2023
P/E
-0.09
Forward P/E
-
PEG
0.01
P/S
0.9
P/B
-0.15
P/C
0.92
P/FCF
-0.1
Quick Ratio
0.27
Current Ratio
0.67
Debt / Equity
-3.32
LT Debt / Equity
-3.32
-
-
EPS (TTM)
-4.19
EPS next Y
-
EPS next Q
-
EPS this Y
-72.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.35%
Revenue last 5Y
NAN%
Revenue Q/Q
2.94%
EPS Q/Q
-37.82%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.99%
Inst Trans
1%
ROA
-49%
ROE
231%
ROC
-0.46%
Gross Margin
59%
Oper. Margin
-644%
Profit Margin
-1014%
Payout
-
Shs Outstand
7.71M
Shs Float
7.62M
-
-
-
-
Target Price
-
52W Range
0.28-10.0
52W High
-
52W Low
-
RSI
27
Rel Volume
0.96
Avg Volume
1.3K
Volume
1.25K
Perf Week
0%
Perf Month
28.57%
Perf Quarter
-
Perf Half Y
-74.65%
-
-
-
-
Beta
1.028
-
-
Volatility
0%, 0.03%
Prev Close
0%
Price
0.36
Change
0%

ASP.TO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.275.732.580.74-0.54
Net income per share
-7.13-14.59-11.03-16.7-4.61
Operating cash flow per share
0.08-4.76-7.78-15.15-3.06
Free cash flow per share
0.08-4.95-7.86-15.15-3.07
Cash per share
2.582.974.016.260.28
Book value per share
4.84-0.06-8.772.16-3.38
Tangible book value per share
-5.44-6.22-12.110.7-3.43
Share holders equity per share
4.84-0.06-8.772.16-3.38
Interest debt per share
4.047.2614.896.73.28
Market cap
350.62K339.62K405.25K413.52K2.17M
Enterprise value
1.76M4.8M14.64M-491.48K23.62M
P/E ratio
-0.04-0.02-0.03-0.02-0.06
Price to sales ratio
0.050.050.110.38-0.53
POCF ratio
3.54-0.06-0.04-0.02-0.09
PFCF ratio
3.54-0.05-0.04-0.02-0.09
P/B Ratio
0.06-4.78-0.030.13-0.08
PTB ratio
0.06-4.78-0.030.13-0.08
EV to sales
0.270.653.88-0.45-5.71
Enterprise value over EBITDA
-0.28-0.3-1.10.02-0.75
EV to operating cash flow
17.81-0.78-1.290.02-1
EV to free cash flow
17.81-0.75-1.270.02-1
Earnings yield
-24.85-55.31-39.8-59.06-16.33
Free cash flow yield
0.28-18.77-28.37-53.61-10.86
Debt to equity
0.77-116.72-1.572.61-0.91
Debt to assets
0.210.491.30.492.45
Net debt to EBITDA
-0.23-0.28-1.070.04-0.68
Current ratio
1.521.351.231.980.72
Interest coverage
-18.79-13.08-6.79-13.7-19.63
Income quality
-0.010.330.710.910.7
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.841.425.17-1.7
Research and developement to revenue
0.340.330.752.33-1.59
Intangibles to total assets
0.560.470.320.130.03
Capex to operating cash flow
00.040.0100
Capex to revenue
0-0.03-0.0300.02
Capex to depreciation
0-0.13-0.10-0.11
Stock based compensation to revenue
0.090.060.050.6-0.26
Graham number
27.864.2546.6528.4918.74
ROIC
-0.67-1.69-1.2-1.7116.13
Return on tangible assets
-0.9-2.11-1.53-1.65-3.81
Graham Net
-8.43-8.53-14.48-1.65-4.02
Working capital
2.79M1.96M1.73M6.93M-3.42M
Tangible asset value
-6.65M-8M-17.72M1.02M-26.35M
Net current asset value
-8.13M-9.27M-19.04M212K-27.02M
Invested capital
0.77-116.72-1.572.61-0.91
Average receivables
3.53M1.48M878.5K1.05M943K
Average payables
1.41M1.3M1.2M1.05M2.08M
Average inventory
3.37M2.74M2M1.9M3.46M
Days sales outstanding
104.3355.0762.38492.5-37.27
Days payables outstanding
135.6948.72167.98197.181K
Days of inventory on hand
333.2388.6247.98419.191.5K
Receivables turnover
3.56.635.850.74-9.79
Payables turnover
2.697.492.171.850.36
Inventory turnover
1.14.121.470.870.24
ROE
-1.47264.591.26-7.731.36
Capex per share
0-0.19-0.080-0.01

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.080.10.10.10.1
Net income per share
-0.64-1.16-1.1-1.19-0.74
Operating cash flow per share
-0.59-0.94-0.61-0.79-1.02
Free cash flow per share
-0.59-0.95-0.7-0.89-1.07
Cash per share
0.30.280.460.170.39
Book value per share
-2.42-3.38-0.6-1.52-1.8
Tangible book value per share
-2.68-3.43-5.37-6.28-6.56
Share holders equity per share
-2.42-3.38-0.6-1.52-1.8
Interest debt per share
2.343.064.785.46.19
Market cap
2.19M2.17M2.21M2.15M2.03M
Enterprise value
16.93M23.62M33.97M41.22M45.14M
P/E ratio
-0.11-0.06-0.07-0.06-0.09
Price to sales ratio
3.732.942.832.872.63
POCF ratio
-0.49-0.3-0.47-0.36-0.26
PFCF ratio
-0.49-0.3-0.41-0.31-0.25
P/B Ratio
-0.12-0.08-0.48-0.18-0.15
PTB ratio
-0.12-0.08-0.48-0.18-0.15
EV to sales
28.843243.4455.1158.62
Enterprise value over EBITDA
-4.44-2.62-6.27-6.22-17.45
EV to operating cash flow
-3.75-3.26-7.29-6.82-5.73
EV to free cash flow
-3.75-3.23-6.34-6.01-5.46
Earnings yield
-2.24-4.12-3.81-4.27-2.81
Free cash flow yield
-2.06-3.37-2.42-3.19-4.08
Debt to equity
-0.91-0.91-7.66-3.45-3.32
Debt to assets
1.52.450.740.890.97
Net debt to EBITDA
-3.87-2.38-5.86-5.9-16.66
Current ratio
0.710.720.490.370.67
Interest coverage
-6.24133.69-3.72-5.32-1.73
Income quality
0.920.80.670.761.89
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
2.34.481.652.992.51
Intangibles to total assets
0.180.030.770.810.77
Capex to operating cash flow
00.010.150.130.05
Capex to revenue
0-0.08-0.89-1.09-0.51
Capex to depreciation
0-0.75-12.19-14.52-6.91
Stock based compensation to revenue
0.570.40.30.240.12
Graham number
5.899.423.846.395.48
ROIC
7.334.31-0.21-0.27-0.11
Return on tangible assets
-0.53-0.96-0.76-1.05-0.52
Graham Net
-3.24-4.02-6-6.86-7.16
Working capital
-3.55M-3.42M-10.78M-13.62M-5.04M
Tangible asset value
-20.64M-26.35M-41.27M-48.36M-50.53M
Net current asset value
-21.29M-27.02M-41.98M-49.02M-51.15M
Invested capital
-0.91-0.91-7.66-3.45-3.32
Average receivables
1.76M1.31M530.5K833K1.08M
Average payables
1.72M2.66M3.09M2.99M2.59M
Average inventory
2.39M3.46M4.52M4.49M4.84M
Days sales outstanding
337.1651.4673.54123.57132.19
Days payables outstanding
412.45703.741.12K534.951.04K
Days of inventory on hand
426.261.05K1.59K851.352.28K
Receivables turnover
0.271.751.220.730.68
Payables turnover
0.220.130.080.170.09
Inventory turnover
0.210.090.060.110.04
ROE
0.260.341.830.780.41
Capex per share
0-0.01-0.09-0.11-0.05

ASP.TO Frequently Asked Questions

What is Acerus Pharmaceuticals Corporation stock symbol ?

Acerus Pharmaceuticals Corporation is a CA stock , located in Mississauga of On and trading under the symbol ASP.TO

What is Acerus Pharmaceuticals Corporation stock quote today ?

Acerus Pharmaceuticals Corporation stock price is $0.36 today.

Is Acerus Pharmaceuticals Corporation stock public?

Yes, Acerus Pharmaceuticals Corporation is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Check Those
Similar Market Cap